Results 141 to 150 of about 51,398 (196)

The occurrence of malignant carcinoid syndrome in patients with carcinoid tumors.

open access: closedBratislavske lekarske listy, 2002
The carcinoid syndrome occurs in about 10% of patients with carcinoid tumors.The main objective of the present study was to determine the presence of the carcinoid syndrome in a group of patients with carcinoid tumor.35 pts with carcinoid tumors (group A--24 pts with metastatic disease, group B--11 pts after resection of the primary tumor with no ...
S, Kinova   +7 more
openaire   +2 more sources

Gastrointestinal carcinoids and the malignant carcinoid syndrome.

open access: closedSurgery, gynecology & obstetrics, 1981
The records of 59 patients with gastrointestinal carcinoid tumors at The New York Hospital from 1948 to 1978 were reviewed. Forty-seven instances were diagnosed surgically; 12 were identified on autopsy specimens. The average age at diagnosis was 55.8 years. No association with duodenal ulcer or carcinoma could be made. The appendix was the mose common
H, Beaton, W, Homan, P, Dineen
openaire   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue.

New England Journal of Medicine, 1986
We studied the effects of a long-acting analogue of somatostatin (SMS 201-995, Sandoz) in 25 patients with histologically proved metastatic carcinoid tumors and the carcinoid syndrome.
L. Kvols   +5 more
semanticscholar   +1 more source

Octreotide acetate long-acting formulation versus open-label subcutaneous octreotide acetate in malignant carcinoid syndrome.

Journal of Clinical Oncology, 1999
PURPOSE Subcutaneous (SC) octreotide acetate effectively relieves the diarrhea and flushing associated with carcinoid syndrome but requires long-term multiple injections daily.
J. Rubin   +8 more
semanticscholar   +1 more source

Malignant carcinoid syndrome: Two case reports

Journal of Surgical Oncology, 1980
AbstractThe malignant carcinoid syndrome (MCS) is a rare complication of malignant carcinoid neoplasms, fewer than 200 cases having been reported since its description by Thorson in 1954. Its signs and symptoms vary with the site of the primary neoplasm, and MCS is now recognized as one member of the large family of endocrine tumors ‐ APUDOMAS ...
Michael E. Sandlin   +2 more
openaire   +3 more sources

Malignant carcinoid. Metastasis to skin and production of carcinoid syndrome, hypertension, diarrhea, dementia, and hypopotassemia: a case report.

Archives of Internal Medicine, 1962
Oberndorfer1in 1907 coined the term carcinoid (karzinoide) for this particular type of tumor of the small bowel; but Lubarsch,2in 1888, had described these tumors which he considered to be different from adenocarcinomas of the ileum.
C. W. Steele
semanticscholar   +1 more source

Diagnosis and Treatment of Malignant Carcinoid Syndrome

JAMA: The Journal of the American Medical Association, 1974
THE malignant carcinoid syndrome has challenged the skills of the clinician, biochemist, and pharmacologist since its original description by Biorck et al 1 22 years ago. Although attention originally centered on a symptom complex and a serotonin-producing midintestinal neoplasm that had metastasized to the liver, the carcinoid syndrome has now been ...
openaire   +3 more sources

Heart disease and the malignant carcinoid syndrome

The American Journal of Surgery, 1970
Abstract A case of the malignant carcinoid syndrome is reported. The anatomic features of the cardiac involvement were of particular interest because of the degree of atrial fibrosis and its probable functional significance. The presence of large quantities of ground substance was noted in the right side of the heart.
openaire   +3 more sources

Brain and other central nervous system tumor statistics, 2021

Ca-A Cancer Journal for Clinicians, 2021
Carol Kruchko   +2 more
exaly  

Home - About - Disclaimer - Privacy